Insiders · EGRX

EGRX insider transactions

Eagle Pharmaceuticals Inc. (EGRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

EGRX insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Eagle Pharmaceuticals Inc., latest first. Follow anyone to get their next filing.

• Christopher KrawtschukChief Financial Officer, since November 2024
• Scott Tarriff10% owner-$1.83M
• Brian Joseph CahillChief Financial Officer
• Michael GravesOfficer, Director
• Steven B RatoffDirector
• Jennifer K. SimpsonDirector
• Robert GlenningDirector
• Richard A. EdlinDirector-$211K
• Luciana BorioDirector, since April 2021
• Michael Shawn MoranOfficer, since September 2021
• David PernockOfficer
• Judith Ng-CashinOfficer

Recent Form 3, 4, and 5 filings for EGRX

• 722d
  SEC Form 3 filed by new insider Krawtschuk Christopher

  3 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 985d
  Tarriff Scott covered exercise/tax liability with 2,119 shares, decreasing direct ownership by 0.46% to 460,621 units (SEC Form 4)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 986d
  Cahill Brian Joseph was granted 3,800 shares and covered exercise/tax liability with 1,589 shares, increasing direct ownership by 5% to 47,958 units (SEC Form 4)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 986d
  Tarriff Scott was granted 12,950 shares and covered exercise/tax liability with 3,154 shares, increasing direct ownership by 2% to 462,740 units (SEC Form 4)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1009d
  Cahill Brian Joseph covered exercise/tax liability with 934 shares, decreasing direct ownership by 2% to 45,747 units (SEC Form 4)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1037d
  Cahill Brian Joseph covered exercise/tax liability with 735 shares, decreasing direct ownership by 2% to 46,681 units (SEC Form 4)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1037d
  Tarriff Scott covered exercise/tax liability with 4,322 shares, decreasing direct ownership by 0.79% to 541,125 units (SEC Form 4)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1055d
  SEC Form 4 filed by Graves Michael

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1057d
  Cahill Brian Joseph covered exercise/tax liability with 452 shares, decreasing direct ownership by 0.94% to 47,416 units (SEC Form 4)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1104d
  Tarriff Scott sold $299,309 worth of shares (21,619 units at $13.84), decreasing direct ownership by 4% to 545,447 units (SEC Form 4)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1107d
  Graves Michael exercised 9,360 shares at a strike of $4.94, increasing direct ownership by 936% to 10,360 units (SEC Form 4)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1134d
  Tarriff Scott sold $300,026 worth of shares (20,245 units at $14.82), decreasing direct ownership by 3% to 567,066 units (SEC Form 4)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1273d
  SEC Form 4 filed by Tarriff Scott

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1276d
  SEC Form 4 filed by Tarriff Scott

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1343d
  SEC Form 4 filed by Ratoff Steven B

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1343d
  SEC Form 4 filed by Graves Michael

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1343d
  SEC Form 4 filed by Simpson Jennifer K.

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1343d
  SEC Form 4 filed by Glenning Robert

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1343d
  SEC Form 4 filed by Edlin Richard A.

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1343d
  SEC Form 4 filed by Borio Luciana

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1350d
  SEC Form 4: Cahill Brian Joseph covered exercise/tax liability with 718 shares and was granted 18,500 shares, increasing direct ownership by 59% to 47,868 units (tax withholding)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1350d
  SEC Form 4: Tarriff Scott covered exercise/tax liability with 3,113 shares and was granted 70,900 shares, increasing direct ownership by 4% to 1,639,934 units (withholding tax)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1374d
  SEC Form 4: Cahill Brian Joseph covered exercise/tax liability with 785 shares, decreasing direct ownership by 3% to 30,086 units to satisfy withholding tax

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1380d
  SEC Form 4: Cahill Brian Joseph covered exercise/tax liability with 601 shares, decreasing direct ownership by 2% to 30,871 units (tax liability)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1387d
  SEC Form 4: Tarriff Scott covered exercise/tax liability with 3,732 shares, decreasing direct ownership by 0.24% to 1,572,147 units (tax liability)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1402d
  SEC Form 4: Cahill Brian Joseph covered exercise/tax liability with 734 shares, decreasing direct ownership by 2% to 31,472 units (for tax liability)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1402d
  SEC Form 4: Tarriff Scott covered exercise/tax liability with 3,827 shares, decreasing direct ownership by 0.24% to 1,575,879 units to satisfy tax liability

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1421d
  SEC Form 4: Cahill Brian Joseph covered exercise/tax liability with 461 shares, decreasing direct ownership by 1% to 32,206 units to satisfy withholding obligation

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1525d
  SEC Form 4: Edlin Richard A. sold $210,732 worth of shares (6,800 units at $30.99), decreasing direct ownership by 23% to 22,600 units

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1715d
  SEC Form 4 filed by Borio Luciana

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1715d
  SEC Form 4: Moran Michael Shawn was granted 10,400 shares, increasing direct ownership by 48% to 32,115 units

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1715d
  SEC Form 4: Cahill Brian Joseph was granted 8,000 shares, increasing direct ownership by 32% to 32,667 units

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1715d
  SEC Form 4 filed by Edlin Richard A.

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1715d
  SEC Form 4 filed by Simpson Jennifer K.

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1715d
  SEC Form 4 filed by Ratoff Steven B

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1715d
  SEC Form 4: Tarriff Scott was granted 34,800 shares, increasing direct ownership by 2% to 1,579,706 units

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1715d
  SEC Form 4 filed by Graves Michael

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1715d
  SEC Form 4 filed by Glenning Robert

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1741d
  SEC Form 4: Cahill Brian Joseph covered exercise/tax liability with 805 shares, decreasing direct ownership by 3% to 24,667 units to satisfy tax liability

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1741d
  SEC Form 4: Moran Michael Shawn covered exercise/tax liability with 742 shares, decreasing direct ownership by 3% to 21,715 units to satisfy tax liability

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1744d
  SEC Form 4: Moran Michael Shawn covered exercise/tax liability with 210 shares, decreasing direct ownership by 0.93% to 22,457 units (tax withholding)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1744d
  SEC Form 4: Cahill Brian Joseph covered exercise/tax liability with 626 shares, decreasing direct ownership by 2% to 25,472 units (tax withholding)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1765d
  SEC Form 4: Moran Michael Shawn covered exercise/tax liability with 90 shares, decreasing direct ownership by 0.40% to 22,667 units (for withholding tax)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1765d
  SEC Form 4: Cahill Brian Joseph covered exercise/tax liability with 263 shares, decreasing direct ownership by 1.00% to 26,098 units to satisfy withholding obligation

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1769d
  SEC Form 4: Moran Michael Shawn covered exercise/tax liability with 1,511 shares, decreasing direct ownership by 6% to 22,757 units (tax withholding)

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1769d
  SEC Form 4: Cahill Brian Joseph covered exercise/tax liability with 738 shares, decreasing direct ownership by 3% to 26,361 units to satisfy withholding tax

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1786d
  SEC Form 4: Cahill Brian Joseph covered exercise/tax liability with 467 shares, decreasing direct ownership by 2% to 27,099 units to satisfy tax liability

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 1861d
  SEC Form 3: New insider Moran Michael Shawn claimed ownership of 24,268 shares

  3 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 2021d
  SEC Form 4 filed by BORIO LUCIANA

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 2021d
  SEC Form 3 filed by BORIO LUCIANA

  3 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 2039d
  SEC Form 4: B Steven Ratoff exercised 7,020 units of Common Stock at a strike of $7.33, increasing direct ownership by 35% to 27,364 units

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 2044d
  SEC Form 4: B Steven Ratoff exercised 2,340 units of Common Stock at a strike of $8.78, increasing direct ownership by 13% to 20,344 units

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 2046d
  SEC Form 4: Scott Tarriff gifted 16,340 units of Common Stock, exercised 31,201 units of Common Stock at a strike of $8.78 and disposed of $681,560 worth of Common Stock (16,278 units at $41.87), decreasing direct ownership by 0.09% to 1,544,906 units

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 2106d
  SEC Form 4 filed by K. Jennifer Simpson

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 2106d
  SEC Form 4 filed by B Steven Ratoff

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 2106d
  SEC Form 4: David Pernock was granted 9,700 units of Common Stock, increasing ownership by 22% to 54,625 units

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 2106d
  SEC Form 4: Judith Ng-Cashin was granted 2,000 units of Common Stock

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 2106d
  SEC Form 4 filed by Michael Graves

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 2106d
  SEC Form 4 filed by Robert Glenning

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)
• 2106d
  SEC Form 4: Joseph Brian Cahill was granted 8,900 units of Common Stock, increasing ownership by 48% to 27,566 units

  4 - EAGLE PHARMACEUTICALS, INC. (0000827871) (Issuer)